What is West Pharmaceutical Services OCF Margin %?
West Pharmaceutical ServicesWST +1.20%95 OCF Margin % is 10.64% as of Mar. 2026, which is 50% below its 10-year median of 21.32. GuruFocus rates WST with a GF Score™ of 95/100 and a GF Value™ of $361.52 (Fairly Valued). The stock has 9 warning signs investors should review. Among 815 Medical Devices & Instruments companies, West Pharmaceutical Services ranks better than 84.54% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's OCF Margin % distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (WST) has a OCF Margin % of 10.64% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on West Pharmaceutical Services and its competitors. This is 50% below median its historical median of 21.32. Over the past decade, West Pharmaceutical Services' OCF Margin % has ranged from 14.54 to 26.32. According to the industry distribution chart, West Pharmaceutical Services ranks #126 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 15.5%.
Is West Pharmaceutical Services' OCF Margin % too high?
West Pharmaceutical Services' current OCF Margin % of 10.64% is 50% below median its 10-year median of 21.32. Over the past 10 years, this metric has ranged from a low of 14.54 to a high of 26.32. The Medical Devices & Instruments industry median OCF Margin % is 5.86. West Pharmaceutical Services' value of 10.64% is 81.6% above this industry median. Based on the distribution chart, West Pharmaceutical Services ranks #126 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, West Pharmaceutical Services has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' OCF Margin % compare to RMD and MDLN?
According to the Medical Devices & Instruments industry distribution chart, West Pharmaceutical Services ranks #126 out of 815 companies for OCF Margin %. This places West Pharmaceutical Services in the top 16% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. West Pharmaceutical Services' value of 10.64% is 81.6% above this benchmark. Historically, West Pharmaceutical Services' own OCF Margin % has ranged from 14.54 to 26.32 over the past decade. While the company's 10-year median is 21.32 vs. the industry median of 5.86, West Pharmaceutical Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. West Pharmaceutical Services's current OCF Margin % of 10.64% is 81.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on West Pharmaceutical Services and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Pharmaceutical Services's current OCF Margin % is 10.64%, which is 50% below median its own 10-year median of 21.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
Based on GuruFocus' analysis, West Pharmaceutical Services (WST) is currently considered Fairly Valued. The stock's GF Value™ is $361.52, compared to a current price of $340.41 — trading 5.8% below its estimated fair value. The current OCF Margin % is 10.64%, which is 50% below median its 10-year median of 21.32 and 81.6% above the Medical Devices & Instruments industry median of 5.86. West Pharmaceutical Services' overall GF Score™ is 95/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For West Pharmaceutical Services (WST), the current OCF Margin % is 10.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is West Pharmaceutical Services (WST) Overvalued in 2026?
Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued.
The current stock price of $340.41 is trading 5.8% below its estimated GF Value™ of $361.52.
GuruFocus considers West Pharmaceutical Services to be Fairly Valued.
Key valuation signals for WST:
OCF Margin %: 10.64% (50% below median its 10-year median of 21.32)
GF Value™: $361.52 vs. price of $340.41 (5.8% below fair value)
Industry Position: 81.6% above the Medical Devices & Instruments median (#126 of 815)
No single metric tells the full story. See the WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
95GF Score
Get the complete analysis for WST
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WST has been successfully added to your 
